Avid Bioservices Inc (CDMO)

[stockaxe]

I'm much higher, but over a longer period of time. I could see myself owning this for 5 or even 10 more years given how strong the industry backdrop is and how well the Company is executing. I would expect another announcement on expansion plans probably within the next 12-15 months as well, just given the lead time for new construction. Over the next five years, you could see a business with over $500mm of revenue and probably $175mm of EBITDA annually. That's mid $50s to high $60s, which is a great IRR even over 5 years. Not without risks of course, but I'm not that focused on where this is at Dec 2022 and much more focused on the potential over the long-run.